"Anybody who has lived in this space would tell you that reimbursement is problems number one, two, three, four, and five," says chief executive Gabriel Otte.
from Forbes Real Time https://www.forbes.com/sites/matthewherper/2018/05/23/freenome-sets-sights-on-blood-test-to-detect-colon-cancer/
via IFTTT
No comments:
Post a Comment